Scientific program

14:00-14:30 Opening words

Chair of the Symposium Juha Sinisalo


 

Session 1 Recent development

chairman Juha Sinisalo

 

14:30-14:55

Genome-wide analysis: A critical approach

Mark Daly, Finland

 

15:00-15:25

Understanding relationships between diet, the microbiome and disease 

Rob Knight, USA


 

Session 2 Risk profiles and prevention 

chairman Katriina Aalto-Setälä

 

16:30-16:55

Sex differences in CVD

Nanette Wenger, USA

 

17:00-17:25

Genome-based prediction & prevention of cardiovascular disease – a practical approach

Elisabeth Widen, Finland

 


 

Session 3 Heart failure 1

chairman Jussi Naukkarinen

 

17:30-17:55

Widening spectrum of heart failure

Rudolf de Boer, Netherlands

 

Session 4 Coronary artery disease

chairman Juha Sinisalo

 

08:30-08:55

Novel imaging

Koen Nieman, USA

 

09:00-09:25

Gene therapies in CVD

Seppo Ylä-Herttuala, Finland

 


 

Session 5 Arrhythmias

chairman Kimmo Kontula

 

10:00-10:25

Cell and tissue modelling for atrial fibrillation

Lior Gepstein, Israel

 

10:30-10:55

Precision treatment of inherited cardiac channelopathies

Arthur Wilde, Netherlands

 

11:00-11:25

The molecular autopsy for SCDY

Michael J Ackerman, USA

 


 

Session 6 Heart failure 2

chairman Jussi Naukkarinen

 

15:30-15:55

Stem cell therapies

Gabor Foldes, UK


 

Session 7 Hypertension

chairman Timo Hiltunen

 

16:15-16:40

Refining future targets for antihypertensive treatment

Jan A Staessen, Belgium

 

16:45-17:10

Hypertension Precision Medicine

Sandosh Padmanabhan, UK

 

17:15-17:40

Device therapy in hypertension

Wilko Spiering, Netherlands

Session 8 Pharmacogenetics

chairman Mikko Niemi

 

09:00-09:25

Pharmacogenomics and cardiovascular precision healthcare

Mark Caulfield, UK

 

09:30-09:55

Personalized approach for statin treatment

Mikko Niemi, Finland

 

10:00-10:25

Implementing pharmacogenomics in clinical practice

Henk-Jan Guchelaar, Netherlands


 

Session 9 Futurology

chairman Juha Sinisalo

 

11:00-11:25 

iPSC as predictive models

Mark Mercola, US

 

11:30-11:55

Future of genome editing techniques in personalized treatment

Bruce Conklin, US


 

12:00 Closing words

We reserve all rights for schedule changes. Version 17.08.2022